Umbhali: Joan Hall
Umhla Wokudalwa: 25 Eyomdumba 2021
Hlaziya Umhla: 20 Eyenkanga 2024
Anonim
Витамин В2 (рибофлавин)
Ividiyo: Витамин В2 (рибофлавин)

Umxholo

URiboflavin ngu-B vitamin. Iyabandakanyeka kwiinkqubo ezininzi emzimbeni kwaye iyimfuneko ekukhuleni kweseli kunye nokusebenza. Inokufumaneka kokutya okuthile njengobisi, inyama, amaqanda, amandongomane, umgubo otyebileyo kunye nemifuno eluhlaza. I-Riboflavin isetyenziswa rhoqo ngokudibanisa nezinye iivithamini B kwiimveliso ezinobunzima ze-vitamin B.

Abanye abantu bathatha i-riboflavin ngomlomo ukukhusela amanqanaba asezantsi e-riboflavin (ukusilela kwe-riboflavin) emzimbeni, kwiintlobo ezahlukeneyo zomhlaza, kunye nentloko ye-migraine. Kwakhona kuthathwa ngomlomo ngenxa yamabala, iicramps ze-muscle, ukutshisa kweenyawo ze-carpal, kunye neengxaki zegazi ezifana ne-congenital methemoglobinemia kunye ne-red cell aplasia. Abanye abantu basebenzisa i-riboflavin kwiimeko zamehlo kubandakanya ukudinwa kwamehlo, i-cataract, kunye ne-glaucoma.

Abanye abantu bathatha i-riboflavin ngomlomo ukugcina iinwele eziphilileyo, ulusu, kunye neenzipho, ukucothisa ukuguga, ngenxa yezilonda ezinomhlaza, isifo sokuqina kwemithambo, ukulahleka kwememori kubandakanya isifo se-Alzheimer, uxinzelelo lwegazi oluphezulu, ukutsha, isifo sesibindi, kunye ne-sickle cell anemia.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe RIBOFLAVIN zezi zilandelayo:


Ukusebenza ...

  • Ukuthintela nokunyanga amanqanaba aphantsi e-riboflavin (ukusilela kwe-riboflavin). Kubantu abadala kunye nabantwana abane-riboflavin encinci emzimbeni wabo, ukuthatha i-riboflavin ngomlomo kunokunyusa amanqanaba e-riboflavin emzimbeni.

Inokwenzeka ukuba isebenze ...

  • IimpawuAbantu abadla i-riboflavin ngakumbi njengenxalenye yokutya kwabo babonakala benomngcipheko ophantsi wokuphuhliswa kwamehlo. Kwakhona, ukuthatha izongezo eziqukethe i-riboflavin kunye ne-niacin kubonakala ngathi kunceda ukuthintela i-cataract.
  • Amanani aphezulu e-homocysteine ​​egazini (hyperhomocysteinemia). Ukuthatha i-riboflavin ngomlomo iiveki ezili-12 kunciphisa amanqanaba e-homocysteine ​​ukuya kuthi ga kwi-40% kwabanye abantu. Kwakhona, ukuthatha i-riboflavin kunye ne-folic acid kunye ne-pyridoxine kubonakala ngathi kunciphisa amanqanaba e-homocysteine ​​ngama-26% kubantu abanamanqanaba aphezulu e-homocysteine ​​abangelwa ngamachiza asetyenziselwa ukuthintela ukuxhuzula.
  • Intloko ye-Migraine. Ukuthatha i-dose ephezulu ye-riboflavin ngomlomo kubonakala kunciphisa inani lokuhlaselwa kwentloko ye-migraine, malunga nokuhlaselwa kwe-2 ngenyanga. Ukuthatha i-riboflavin ngokudibeneyo kunye nezinye i-vithamin sand sand minerals kubonakala ngathi kunciphisa inani leentlungu ezikhoyo ngexesha le-migraine.

Kusenokwenzeka ukuba ayisebenzi ...

  • Umhlaza wesisu. Ukuthatha i-riboflavin kunye ne-niacin kuyanceda ekuthinteleni umhlaza wesisu.
  • Ukungondleki kubangelwa yiprotheyini encinci ekutyeni (kwashiorkor). Olunye uphando lubonisa ukuba ukuthatha i-riboflavin, i-vitamin E, i-selenium, kunye ne-N-acetyl cysteine ​​ngomlomo akunciphisi ulwelo, ukunyusa ukuphakama okanye ubunzima, okanye ukunciphisa usulelo kubantwana abasemngciphekweni we-kwashiorkor.
  • Umhlaza wemiphunga. Ukuthatha i-riboflavin ngomlomo kunye ne-niacin akuncedi ekuthinteleni umhlaza wemiphunga.
  • Isifo seengcongconi. Ukuthatha i-riboflavin kunye ne-iron, i-thiamine, kunye ne-vitamin C ngomlomo, akunciphisi inani okanye ubuzaza bosulelo lwe-malaria kubantwana abasemngciphekweni wokuvezwa sisifo seengcongconi.
  • Uxinzelelo lwegazi xa ukhulelwe (pre-eclampsia). Kwabasetyhini abaneenyanga ezine bekhulelwe, ukuqala ukuthatha i-riboflavin ngomlomo kunciphisa umngcipheko we-pre-eclampsia ngexesha lokukhulelwa.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • I-Lactic acidosis (ukungalingani kwegazi-acid) kubantu abane-syndrome ye-immunodeficiency (AIDS). Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin ngomlomo kunokuba luncedo ekunyangeni i-lactic acidosis ebangelwa ngamachiza abizwa ngokuba yi-nucleoside analog reverse transcriptase inhibitors (NRTIs) kwizigulana ezine-immunodeficiency syndrome (AIDS).
  • Umhlaza womlomo wesibeleko. Ukunyuka kokutya kwe-riboflavin kwimithombo yokutya kunye neyokuncedisa, kunye ne-thiamine, i-folic acid, kunye ne-vitamin B12, kunokunciphisa umngcipheko wokuba nomhlaza womlomo wesibeleko.
  • Umhlaza wombhobho wokutya (umhlaza we-esophageal). Uphando malunga nefuthe le-riboflavin yokuthintela umhlaza we-esophageal iyaphikisana. Olunye uphando lubonisa ukuba ukuthatha i-riboflavin ngomlomo kunokunciphisa umngcipheko wokufumana umhlaza we-esophageal, ngelixa olunye uphando lubonisa ukuba alunampembelelo.
  • Igazi elonyukayo. Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin ngomlomo kwizigulana ezithile ezisengozini ephezulu yoxinzelelo lwegazi ngenxa yokwahluka kwemfuza kunokuhlisa uxinzelelo lwegazi xa isetyenziswa ukongeza kumayeza oxinzelelo lwegazi.
  • Umhlaza wesibindi. Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin kunye ne-niacin ngomlomo kunokunciphisa umngcipheko womhlaza wesibindi kubantu abangaphantsi kweminyaka engama-55 ubudala. Nangona kunjalo, kubonakala ngathi awunciphisi umngcipheko womhlaza wesibindi kubantu abadala.
  • Isifo sokugubhuka. Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin ngomlomo iinyanga ezi-6 akuphuculi ukukhubazeka kwizigulana ezine-multiple sclerosis.
  • Amabala amhlophe ngaphakathi komlomo (ngomlomo leukoplakia). Uphando lwakwangoko lubonisa ukuba amanqanaba asezantsi e-riboflavin egazini adibene nomngcipheko okhulayo we-leukoplakia yomlomo. Nangona kunjalo, ukuthatha izongezo ze-riboflavin ngomlomo kangangeenyanga ezingama-20 akubonakali ngathi kuthintela okanye kunyanga i-leukoplakia yomlomo.
  • Ukunqongophala kwentsimbi ngexesha lokukhulelwa. Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin, i-iron, kunye ne-folic acid ngomlomo akonyusi amanqanaba e-iron kwabasetyhini abakhulelweyo ngaphezulu kokuthatha nje i-iron kunye ne-folic acid.
  • Isifo seSickle cell. Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin ngomlomo iiveki ezi-8 kunyusa amanqanaba e-iron kubantu abanamanqanaba asezantsi e-iron ngenxa yesifo se-sickle cell.
  • Ukubetha. Uphando lwakwangoko lubonisa ukuba ukuthatha i-riboflavin kunye ne-niacin ngomlomo akuthinteli ukufa okunxulumene nokufa icala kubantu abasemngciphekweni wokubethwa.
  • Amabala.
  • Ukwaluphala.
  • Ukunyusa amajoni omzimba.
  • Izilonda zenqanawa.
  • Ukugcina ulusu kunye neenwele zisempilweni.
  • Ukuphulukana nenkumbulo kubandakanya isifo se-Alzheimer's.
  • Iintlanzi zemisipha.
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-riboflavin kwezi zinto zisetyenziswayo.

I-Riboflavin iyadingeka kuphuhliso olufanelekileyo lwezinto ezininzi emzimbeni kubandakanya ulusu, ulwelo lwendlela yokugaya ukutya, iiseli zegazi kunye nokusebenza kwengqondo.

URiboflavin ngu NGOKUKHUSELEKILEYO kubantu abaninzi xa bethathwe ngomlomo. Kwabanye abantu, i-riboflavin inokubangela ukuba umchamo uguqule umbala otyheli-orenji. Inokubangela urhudo.

Amanyathelo okhuseleko kunye nezilumkiso:

Abantwana: URiboflavin ngu NGOKUKHUSELEKILEYO kuninzi lwabantwana xa bethathwe ngomlomo izixa ezifanelekileyo njengoko kucetyisiwe yiBhodi yokuTya kunye nokutya kwiZiko lezeMpilo leSizwe (jonga icandelo lokulinganisa apha ngezantsi).

Ukukhulelwa kunye nokuncancisa: URiboflavin ngu NGOKUKHUSELEKILEYO xa ithathwa ngomlomo kwaye isetyenziswe ngokufanelekileyo kubafazi abakhulelweyo okanye abancancisayo. Inani elinconywayo li-1.4 mg ngosuku kwabasetyhini abakhulelweyo kunye ne-1.6 mg ngosuku kubasetyhini abancancisayo. URiboflavin ngu UKHUSELEKO OLUNOKWENZEKA xa kuthathwa ngomlomo kwiidosi ezinkulu, ixesha elifutshane. Olunye uphando lubonisa ukuba i-riboflavin ikhuselekile xa ithathwa kumthamo we-15 mg kanye kwiiveki ezimbini kwiiveki ezili-10.

IHepatitis, iCirrhosis, isithintelo seBillaryUkufunxwa kweRiboflavin kuyehla kubantu abanezi meko.

Iphakathi
Lumka ngale nhlanganisela.
Iintsholongwane (iTetracycline antibiotics)
I-Riboflavin inokunciphisa inani leetetracyclines ezinokuthi zithathwe ngumzimba. Ukuthatha i-riboflavin kunye ne-tetracyclines kunokunciphisa ukusebenza kwe-tetracyclines. Ukuthintela oku kunxibelelana, thatha i-riboflavin iiyure ezingama-2 ngaphambi okanye iiyure ezi-4 emva kokuthatha i-tetracyclines.

Ezinye i-tetracyclines zibandakanya i-demeclocycline (iDeclomycin), i-minocycline (iMinocin), kunye ne-tetracycline (Achromycin).
Incinci
Jonga olu dibaniso.
Ukomisa amayeza (iziyobisi zeAnticholinergic)
Amanye amayeza okomileyo anokuchaphazela isisu kunye namathumbu. Ukuthatha la mayeza okomisa nge-riboflavin (ivithamini B2) kunokunyusa inani le-riboflavin efunxwe emzimbeni. Kodwa akwaziwa ukuba olu nxibelelwano lubalulekile.
Olunye lala mayeza owomileyo aquka i-atropine, scopolamine, kunye namanye amayeza asetyenziselwa ukwaliwa (antihistamines), kunye nokudakumba (i-antidepressants).
Amayeza oxinzelelo (iTricyclic antidepressants)
Amanye amayeza oxinzelelo anokunciphisa inani le-riboflavin emzimbeni. Oku kunxibelelana akuyiyo inkxalabo enkulu kuba kwenzeka kuphela ngamanani amakhulu kakhulu amayeza oxinzelelo. Amanye amayeza asetyenziselwa uxinzelelo abandakanya i-amitriptyline (Elavil) okanye imipramine (Tofranil, Janimine), kunye nabanye.
IPhenobarbital (iLuminal)
I-Riboflavin idilizwe ngumzimba. I-Phenobarbital inokunyusa ukuba i-riboflavin yaphulwe ngokukhawuleza kangakanani emzimbeni. Akucaci ukuba ngaba olu nxibelelwano lubalulekile.
Iprobenecid (iBenemid)
I-Probenecid (iBenemid) inokunyusa ukuba ingakanani i-riboflavin esemzimbeni. Oku kunokubangela ukuba kubekho i-riboflavin eninzi emzimbeni. Kodwa ayaziwa ukuba le ntsebenziswano yinkxalabo enkulu.
I-psyllium emhlophe
I-Psyllium inciphisa ukufunxwa kwe-riboflavin kwizongezo zabafazi abasempilweni. Akucaci nokuba oku kuyenzeka nge-riboflavin yokutya, okanye kubaluleke kakhulu empilweni.
IBoron
Ifom ye-boron, ebizwa ngokuba yi-boric acid, inokunciphisa ukunyibilika kwe-riboflavin emanzini. Oku kunokunciphisa ukufunxwa kwe-riboflavin.
Ifolic acid
Kubantu abanesimo esibizwa ngokuba yi-methylenetetrahydrofolate reductase (MTHFR) ukusilela, ukuthatha i-folic acid kunokwenza ukuba ukusilela kwe-riboflavin kubhebhetheke. I-folic acid inokunciphisa amanqanaba egazi e-riboflavin kubantu abakule meko.
Intsimbi
Izongezo zeRiboflavin zinokuphucula indlela izongezelelo zentsimbi ezisebenza ngayo kwabanye abantu abangenayo i-iron eyaneleyo. Esi siphumo mhlawumbi sibalulekile kuphela kubantu abanesiphene se-riboflavin.
Ukutya
Ukufunxa izongezo ze-riboflavin kunokunyuswa xa kuthathwa kunye nokutya.
La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA

NGOMLOMO:
  • NgokubanziIsibonelelo esinconywayo sokutya (i-RDA) se-riboflavin kubantu abadala yi-1.3 mg ngosuku emadodeni, i-1.1 mg ngosuku ngabafazi, i-1.4 mg ngosuku kubantu ababhinqileyo abakhulelweyo, kunye ne-1.6 mg ngosuku kubafazi abancancisayo. Akukho manqanaba okutya okuphezulu mihla le (i-UL) ye-riboflavin, elilelona nqanaba liphezulu lokutya elinokubangela umngcipheko weziphumo ezibi.
  • Ukuthintela nokunyanga amanqanaba asezantsi e-riboflavin (ukusilela kwe-riboflavin)Kusetyenziswe iRiboflavin 5-30 mg yonke imihla.
  • NgamehloIndibaniselwano ye-riboflavin 3 mg kunye ne-niacin 40 mg yonke imihla kangangeminyaka emi-5-6 isetyenzisiwe.
  • Kwinqanaba eliphezulu le-homocysteine ​​egazini): I-Riboflavin 1.6 mg yonke imihla isetyenzisiwe kwiiveki ezili-12. Umdibaniso oqukethe i-75 mg ye-riboflavin, i-0.4 mg ye-folic acid, kunye ne-120 mg ye-pyridoxine mihla le kwiintsuku ezingama-30 nayo isetyenzisiwe.
  • Ngenxa yeentloko ze-migraine: Elona dose liqhelekileyo yi-riboflavin 400 mg yonke imihla ubuncinci iinyanga ezintathu. Imveliso ethile (iDolovent; Linpharma Inc., Oldsmar, FL) isetyenziswe kwiifomsile ezimbini kusasa kunye neepilisi ezimbini ngokuhlwa kwiinyanga ezi-3 nazo zisetyenzisiwe. Le dosi ibonelela ngenani elipheleleyo le-riboflavin 400 mg, i-magnesium 600 mg, kunye ne-coenzyme Q10 150 mg ngosuku.
ABANTWANA

NGOMLOMO:
  • NgokubanziIsibonelelo sokutya esinconywayo (RDA) se-riboflavin yi-0.3 mg ngosuku kwiintsana ukuya kwiinyanga ezi-6 ubudala, i-0.4 mg ngosuku kwiintsana ezinenyanga ezi-6 ukuya kwezi-12 ubudala, i-0.5 mg ngosuku kubantwana abaneminyaka engama-1-3 ubudala, i-0.6 mg nganye usuku lwabantwana abaneminyaka engama-4-8 ubudala, i-0.9 mg ngosuku kubantwana abaneminyaka engama-9-13 ubudala, i-1.3 mg ngosuku ngamadoda aneminyaka eyi-14-18 ubudala, kunye ne-1.0 mg ngosuku kubantu ababhinqileyo 14-18. Akukho manqanaba okutya okuphezulu mihla le (i-UL) ye-riboflavin, elilelona nqanaba liphezulu lokutya elinokuthi lingabeki mngcipheko weziphumo ezibi.
  • Ukuthintela nokunyanga amanqanaba asezantsi e-riboflavin (ukusilela kwe-riboflavin)I-Riboflavin 2 mg kube kanye, emva koko kusetyenziswa i-0.5-1.5 mg yonke imihla kangangeentsuku ezili-14. I-Riboflavin 2-5 mg imihla ngemihla isetyenzisiwe ukuya kwiinyanga ezimbini. I-Riboflavin 5 mg iintsuku ezintlanu ngeveki ukuya kunyaka omnye ikwasetyenzisiwe.
B Complex Vitamin, Complexe de Vitamines B, Flavin, Flavine, Lactoflavin, Lactoflavine, Riboflavin 5 ’Phosphate, Riboflavin Tetrabutyrate, Riboflavina, Riboflavine, Vitamin B2, Vitamin G, Vitamina B2, Vitamine B2, Vitamine G.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. Ukungeniswa kwesalathiso sokutya (i-DRIs): iimfuno eziqikelelweyo zomndilili. Ukutya kunye neBhodi yeZondlo, iZiko lezeMithi, iZifundo zeSizwe. https://www.nal.usda.gov/sites/default/files/fnic_uploads//recommended_intakes_individuals.pdf Ifikeleleke ngoJulayi 24, 2017.
  2. UWilson CP, uMcNulty H, uWadi M, et al. Uxinzelelo lwegazi kubantu abanyangiweyo abane-MTHFR 677TT genotype iyaphendula kungenelelo nge-riboflavin: ukufunyanwa kwetyala ekujoliswe kulo. Uxinzelelo lwegazi. Ngo-2013; 61: 1302-8. Jonga i-abstract.
  3. UWilson CP, uWard M, uMcNulty H, et al. I-Riboflavin ibonelela ngesicwangciso esijolise ekulawuleni uxinzelelo lwegazi kwizigulana ezine-MTHFR 677TT genotype: ukulandelwa kwe-4-y. NdinguJ oNyango lweeKlinikhi. Ngo-2012; 95: 766-72. Jonga i-abstract.
  4. UGaul C, uDiener HC, uDanesch U; Iqela leMigravent Study. Ukuphuculwa kweempawu ze-migraine ngesongezelelo sokuthengisa esine-riboflavin, i-magnesium kunye ne-Q10: uvavanyo olungenamkhethe, olulawulwa yi-placebo, oluyimfama kabini, olunobuninzi. J Intloko kunye nePain. Ngo-2015; 16: 516. Jonga i-abstract.
  5. UNaghashpour M, Majdinasab N, uShakakerinejad G, okqhubekayo. Unyango lweRiboflavin kwizigulana ezine-sclerosis ezininzi alusenzi siphucule imeko yokukhubazeka kwaye isongezelelo se-riboflavin sihambelana ne-homocysteine. Int J Vitam Nutr Res. Ngo-2013; 83: 281-90. Jonga i-abstract.
  6. I-Lakshmi, A. V. Riboflavin metabolism - ukubaluleka kokutya kwabantu. Indiya J Med Res 1998; 108: 182-190. Jonga i-abstract.
  7. Pascale, J. A., Mims, L. C., Greenberg, M.H, Gooden, D. S., kunye noChronister, E. Riboflaven kunye nempendulo ye-bilirubin ngexesha lokufotowa. Umntwana. I-1976; 10: 854-856. Jonga i-abstract.
  8. Madigan, SM, Tracey, F., McNulty, H., Eaton-Evans, J., Coulter, J., McCartney, H., no-Strain, uJJ Riboflavin kunye novithamini B-6 ukungena kunye nenqanaba kunye nempendulo ye-biochemical kwisongezo se-riboflavin kubantu abadala abahlala ngokukhululekileyo. NdinguJ J Clin Nutr 1998; 68: 389-395. Jonga i-abstract.
  9. USammon, A. M. kunye no-Alderson, D. Ukutya, i-reflux kunye nokukhula kwe-squamous cell carcinoma ye-esophagus e-Afrika. U-Br J Ugqirha. Ngo-1998; 85: 891-896. Jonga i-abstract.
  10. UMatimoe, D. noNewton, W. Idosi ephezulu ye-riboflavin ye-migraine prophylaxis. J Fam Ukukhetha. Ngo-1998; 47: 11. Jonga i-abstract.
  11. I-Solomons, N. W. Micronutrients kunye nendlela yokuphila yasezidolophini: izifundo ezivela eGuatemala. IArch Latinoam Nutrut 1997; 47 (2 iSuppl 1): 44-49. Jonga i-abstract.
  12. UWadhwa, A., Sabharwal, M., kunye noSharma, S. Inqanaba lesondlo sabadala. Indiya J Med Res 1997; 106: 340-348. Jonga i-abstract.
  13. Spirichev, VB, Kodentsova, VM, Isaeva, VA, Vrzhesinskaia, OA, Sokol'nikov, AA, Blazhevvich, NV, kunye neBeketova, NA [Isimo seVitamin sabemi abasuka kwimimandla enengxaki yengozi kumzimveliso wamandla eChernobyl, kunye ukulungiswa ngee-multivitamini "iDuovit" kunye ne "Undevit" kunye nemultivitamin premix 730/4 yenkampani "Roche"]. Vopr. IPitan. Ngo-1997;: 11-16. Jonga i-abstract.
  14. D'Avanzo, B., Ron, E., La, Vecchia C., Francaschi, S., Negri, E., kunye noZleglar, R. Ukukhetha ukutya okune-micronutrient kunye ne-thyroid carcinoma. Umhlaza 6-1-1997; 79: 2186-2192. Jonga i-abstract.
  15. I-Kodentsova, VM, Pustograev, NN, Vrzhesinskaia, OA, Kharitonchik, LA, Pereverzeva, OG, Iakushina, LM, Trofimenko, LS, kunye neSpirichev, VB [Ukuthelekiswa kwemetabolism yeevithamini ezinyibilika emanzini kubantwana abasempilweni nakubantwana abane-insulin- isifo seswekile esixhomekekileyo kuxhomekeke kwinqanaba leevithamini kwindlela otya ngayo]. Vopr. UMed Khim. Ngo-1996; 42: 153-158. Jonga i-abstract.
  16. UWynn, M. kunye noWynn, A. Ngaba ukutya okuphuculweyo kunganegalelo kuthintelo lwamehlo? Impilo yeZondlo 1996; 11: 87-104. Jonga i-abstract.
  17. Ito, K. kunye noKawanishi, S. [Umonakalo weDensensitized DNA: iindlela kunye nokusetyenziswa kweklinikhi]. UNihon Rinsho 1996; 54: 3131-3142. Jonga i-abstract.
  18. UPorcelli, P.J, Adcock, E.W, DelPaggio, D., Swift, L.L, kunye noGreene, H.L.Plasma kunye nomchamo i-riboflavin kunye ne-pyridoxine yokugxila kwiindawo zokutya ezinesisindo esiphantsi. J Isicwili sezigulana. Gastroenterol. Nutrut 1996; 23: 141-146. Jonga i-abstract.
  19. UZempleni, J., Galloway, J. R., noMcCormick, D. B. Ukuchongwa kunye ne-kinetics ye-7 i-alpha-hydroxyriboflavin (i-7-hydroxymethylriboflavin) kwi-plasma yegazi ebantwini elandela ukulawulwa ngomlomo kwezixhasi ze-riboflavin. I-Int J Vitam yeNutr Res 1996; 66: 151-157. Jonga i-abstract.
  20. U-Williams, P. G. Ukugcinwa kwe-Vitamin kwindawo yokupheka / yokuphola kunye nokupheka / ngeenkonzo ezishushu zokutya esibhedlele. J Nditya. Assoc. Ngo-1996; 96: 490-498. Jonga i-abstract.
  21. UZempleni, J., Galloway, J. R., kunye noMcCormick, D. B. Pharmacokinetics yomlomo kunye nothintelo olwenziwe nge-riboflavin kubantu abaphilileyo. NdinguJ J Clin Nutriti 1996; 63: 54-66. Jonga i-abstract.
  22. Rosado, J. L., Bourges, H., kunye ne-Saint-Martin, B. [I-Vitamin kunye nokunqongophala kwezimbiwa eMexico. Uphengululo olunzulu ngemeko yobugcisa. II. Ukusilela kweVitamin]. USalud Publica Mex. Ngo-1995; 37: 452-461. Jonga i-abstract.
  23. Amandla, H. J. Riboflavin-iron unxibelelwano kunye nokugxininisa ngokukodwa kwithumbu lesisu. Inkqubo yeNutr Soc 1995; 54: 509-517. Jonga i-abstract.
  24. UHeseker, H. kunye noKubler, W.Ukunyuka okungapheliyo kokutya kweevithamini kunye nenqanaba levithamini yamadoda asempilweni. Isondlo 1993; 9: 10-17. Jonga i-abstract.
  25. I-Igbedioh, S. O. Ukungondleki eNigeria: ubungakanani, oonobangela kunye nezisombululo zokuphelisa imeko eguqukayo yezentlalo nezoqoqosho. Impilo yeZondlo 1993; 9: 1-14. Jonga i-abstract.
  26. Ajayi, O. A., George, B. O., kunye no-Ipadeola, T. Uvavanyo lwezonyango lwe-riboflavin kwisifo se-sickle cell. EMpuma Afr. UMed J 1993; 70: 418-421. Jonga i-abstract.
  27. UZaridze, D., Evstifeeva, T., noBoyle, P. Chemoprevention yomlomo we-leukoplakia kunye ne-esophagitis engapheliyo kwindawo eneziganeko eziphezulu zomhlaza womlomo kunye nokuqaqanjelwa ngumqala. UAnn Epidemiol 1993; 3: 225-234. Jonga i-abstract.
  28. Chen, R. D. [Chemoprevention yomhlaza womlomo wesibeleko-ungenelelo ngoncedo lwezilonda zesibeleko somlomo wesibeleko ngu-retinamide II kunye ne-riboflavin]. UZhonghua Zhong. Liu Za Zhi 1993; 15: 272-274. Jonga i-abstract.
  29. I-Bates, uC. J., Prentice, A. M., noPaul, A. A. Ukwahluka ngokwamaxesha kwiivithamini A, C, riboflavin kunye nokufakwa kwefolate kunye nenqanaba labasetyhini abakhulelweyo nabancancisayo kwindawo yasemaphandleni yaseGambia: ezinye izinto ezinokwenzeka. I-Eur. J yeKlinikhi yeNutriti 1994; 48: 660-668. Jonga i-abstract.
  30. van der Beek, E. J., van, Dokkum W., Wedel, M., Schrijver, J., noVan den Berg, H. Thiamin, riboflavin kunye nevithamini B6: ifuthe lokuthintelwa kokutya emzimbeni womntu. J NdinguColl Nutriti 1994; 13: 629-640. Jonga i-abstract.
  31. UTrygg, K., Lund-Larsen, K., Sandstad, B., Hoffman, H. J., Jacobsen, G., kunye no-Bakketeig, L. S. Ngaba abantu abatshayayo abakhulelweyo batya ngokwahlukileyo kwabo bangatshayiyo? I-Paediatr. I-Perinat. I-Epidemiol 1995; 9: 307-319. Jonga i-abstract.
  32. I-Benton, D., Haller, J., kunye neFordy, J. Vitamin ukuncedisa unyaka omnye uphucula imeko. Neuropsychobiology 1995; 32: 98-105. Jonga i-abstract.
  33. ISchindel, L. Ingxaki ye-placebo. I-Eur. J Clin Pharmacol 5-31-1978; 13: 231-235. Jonga i-abstract.
  34. I-Cherstvova, L. G. [Indima yendalo ye-vitamin B2 kwi-anemia). IGematol.Transfuziol. Ngo-1984; 29: 47-50. Jonga i-abstract.
  35. I-Bates, i-C., I-Flewitt, i-A, i-Prentice, i-A.M, i-Lamb, i-WH kunye ne-Whitehead, i-R. Umsoco weNutr Clinic 1983; 37: 427-432. Jonga i-abstract.
  36. I-Bamji, M. S. Ukusilela kweVitamin kwindawo yokutya irayisi. Iziphumo zokuncedisa i-B-vitamin. Amava eSuppl 1983; 44: 245-263. Jonga i-abstract.
  37. UBamji, M. S., Sarma, K. V., kunye noRadhaiah, G. Ubudlelwane phakathi kweempawu zebhayoloji kunye neeklinikhi zokunqongophala kwe-vitamin B. Isifundo kumakhwenkwe esikolo asezilalini. Br J I-1979; 41: 431-441. Jonga i-abstract.
  38. UHovi, uL., Hekali, uR., Kunye noSiimes, uM. A. Ubungqina bokuncipha kwe-riboflavin kwiintsana ezincancisayo kunye nokuqhubela phambili ngokukhawuleza ngexesha lonyango lwe-hyperbilirubinemia nge-phototherapy. Acta Paediatr. Ngo-1979; 68: 567-570. Jonga i-abstract.
  39. Yabona, C. S. Riboflavin inqanaba lokufikisa laseTshayina emazantsi: izifundo zokugcwalisa i-riboflavin. Umsoco weKlinikhi yeNutr 1985; 39: 297-301. Jonga i-abstract.
  40. URudolph, N., Parekh, A. J., Hittelman, J., Burdige, J., kunye noWong, S. L. Ukwehla emva kokubeleka kwi-pyridoxal phosphate kunye ne-riboflavin. Ukunyanzeliswa kwe-phototherapy. NdinguJ Dis Umntwana 1985; 139: 812-815. Jonga i-abstract.
  41. IHolmlund, D. kunye neSjodin, J. G. Unyango lwe-ureteral colic ene-intravenous indomethacin. J Urol. Ngo-1978; 120: 676-677. Jonga i-abstract.
  42. Amandla, H.J, Bates, C. J., Eccles, M., Brown, H., noGeorge, E. Ukusebenza ngebhayisikile kubantwana baseGambia: iziphumo zokuncedisa i-riboflavin okanye i-ascorbic acid. Umsoco weNutr Clinic 1987; 41: 59-69. Jonga i-abstract.
  43. Pinto, J. T. kunye noRivlin, R. S. Iziyobisi ezikhuthaza ukukhutshwa kwe-renal ye-riboflavin. Ukudibana kweziyobisi. Ngo-1987; 5: 143-151. Jonga i-abstract.
  44. Wahrendorf, J., Munoz, N., Lu, JB, Thurnham, DI, Crespi, M., kunye neBosch, iFX Igazi, i-retinol kunye ne-zinc riboflavin inqanaba ngokunxulumene nezilonda zangaphambi kwesisu: Iziphumo ezivela kuvavanyo lokungenelela kwivithamini iRiphabhlikhi Yabantu yase China. Umhlaza Res 4-15-1988; 48: 2280-2283. Jonga i-abstract.
  45. I-Lin, P. Z., Zhang, J. S., Cao, S. G., Rong, Z. P., Gao, R. Q., Han, R., kunye no-Shu, S. P. [Uthintelo lwesibini lomhlaza wokungenelela-ungenelelo kwizilonda zangaphambi komqala]. UZhonghua Zhong. Liu Za Zhi 1988; 10: 161-166. Jonga i-abstract.
  46. van der Beek, EJ, van, Dokkum W., Schrijver, J., Wedel, M., Gaillard, AW, Wesstra, A., van de Weerd, H., noHermus, RJ Thiamin, riboflavin, kunye neevithamini B- I-6 kunye no-C: ifuthe lokudityaniswa kokuthintelwa kokusebenza kwintsebenzo emntwini. NdinguJ J Clin Nutriti 1988; 48: 1451-1462. Jonga i-abstract.
  47. UZaridze, D. G., Kuvshinov, J. P., Matiakin, E., Polakov, B. I., Boyle, P., kunye noBlettner, M. Chemoprevention yomhlaza womlomo kunye nowesophageal e-Uzbekistan, Union of Soviet Socialist Republics. Natl. ICancer Inst. IMonogr 1985; 69: 259-262. Jonga i-abstract.
  48. UMunoz, N., Wahrendorf, J., Bang, L. J., Crespi, M., Thurnham, D. I., Usuku, N. E., Ji, Z. H., Grassi, A., Yan, L. W., Lin, L. G., kunye. Akukho siphumo se-riboflavine, i-retinol, kunye ne-zinc ekwandeni kwezilonda zangaphambi komqala. Ungenelelo ngongenelelo olwenziwe kabini olungaboniyo kwiindawo ezinobungozi obukhulu base China. ILancet 7-20-1985; 2: 111-114. Jonga i-abstract.
  49. U-Wang, Z. Y. [Ukhuseleko lwe-Chemopre kwindawo ephezulu yomhlaza wemiphunga]. UZhonghua Zhong. Liu Za Zhi 1989; 11: 207-210. Jonga i-abstract.
  50. IHargreaves, M.K, Baquet, C., kunye noGamshadzahi, A. Ukutya, imeko yesondlo, kunye nomngcipheko womhlaza kubantu abamnyama baseMelika. Umhlaza weNutrar 1989; 12: 1-28. Jonga i-abstract.
  51. I-Desai, i-ID, i-Doell, i-AM, i-Officiati, i-SA, i-Bianco, i-AM, i-Van, i-Severen Y., iDesai, i-MI, iJansen, i-E, kunye ne-Oliveira, i-JE yovavanyo lweemfuno zezondlo zabafuduki basemaphandleni basemazantsi eBrazil: ukuyila, ukumilisela kwaye kuvavanywe inkqubo yokufundisa ngesondlo. Ihlabathi uMfu uNutr Ukutya. Ngo-1990; 61: 64-131. Jonga i-abstract.
  52. I-Suboticanec, K., Stavljenic, A., Schalch, W., kunye neBuzina, R. Iziphumo ze-pyridoxine kunye ne-riboflavin yokuxhasa ukomelela komzimba kulutsha olufikisayo. I-Int J Vitam. INutr Res. Ngo-1990; 60: 81-88. Jonga i-abstract.
  53. I-Turkki, P. R., Ingerman, L., Schroeder, L. A., Chung, R. S., Chen, M., Russo-McGraw, M. A., kunye noDearlove, J. Riboflavin ukungena kunye nenqanaba lamabhinqa atyebileyo ngokuziphatha ngexesha lokuqala lonyaka olandelayo emva kokusebenza emva kwesisu. NdinguColl Nutriti 1990; 9: 588-599. Jonga i-abstract.
  54. IHoppel, uC. L. kunye noTandler, uB. Riboflavin. Inkqubo yeClin Biol. 1990; 321: 233-248. Jonga i-abstract.
  55. I-Lin, P. [Unyango lwe-Medicamentous inhibitory yezilonda zangaphambi komqala-3 kunye neminyaka emi-5 yokuthintela isiphumo se-antitumor B, i-retinamide kunye ne-riboflavin]. UZhongguo Yi Xue Ke Xue Yuan Xue Bao 1990; 12: 235-245. Jonga i-abstract.
  56. I-Lin, P., Zhang, J., Rong, Z., Han, R., Xu, S., Gao, R., Ding, Z., Wang, J., Feng, H., kunye noCao, S. Izifundo kunyango lwe-inhibitory yonyango lwe-esophageal precancerous lesions-3- kunye ne-5-iminyaka yokuthintela iziphumo ze-antitumor-B, retinamide kunye ne-riboflavin. Inkqubo yeChin Acad Med Sci Peking. Union Med Coll 1990; 5: 121-129. Jonga i-abstract.
  57. Odigwe, C. C., Smedslund, G., Ejemot-Nwadiaro, R. I., Anyanechi, C., noKrawinkel, M. B. Ukongezwa kwe-vitamin E, i-selenium, i-cysteine ​​kunye ne-riboflavin yokuthintela i-kwashiorkor kubantwana abasaqala isikolo kumazwe asakhasayo. Idatha yedatha yeCochrane. Ngo-2010; CD008147. Jonga i-abstract.
  58. I-Koller, T., Mrochen, M., kunye ne-Seiler, T. Ukuxinana kunye namanqanaba okusilela emva kokunxibelelana kwe-corneal. J Cataract Refract. Utyando. 2009; 35: 1358-1362. Jonga i-abstract.
  59. IMacLennan, S. C., Wade, F. M., Forrest, K. M., Ratanayake, P. D., Fagan, E., kunye no-Antony, J. I-high-dose riboflavin ye-migraine prophylaxis ebantwaneni: ilingo elilawulwa kabini, elingaboniyo, nelilawulwa yi-placebo. J Umntwana Neurol. Ngo-2008; 23: 1300-1304. Jonga i-abstract.
  60. Wittig-Silva, C., Whiting, M., Lamoureux, E., Lindsay, R. G., Sullivan, L. J., kunye no-Snibson, G. R. Uvavanyo olulawulwa ngokungahleliwe lokudityaniswa kwe-corneal collagen kwi-keratoconus eqhubekayo: iziphumo zokuqala. Ukuphinda ujonge. Ngo-2008; 24: S720-S725. Jonga i-abstract.
  61. I-Evers, S. [Olunye uhlobo lwe-beta blockers kunyango lwe-migraine yothintelo]. INervenarzt 2008; 79: 1135-40, 1142. Jonga i-abstract.
  62. Ma, AG, Schouten, EG, Zhang, FZ, Kok, FJ, Yang, F., Jiang, DC, Sun, YY, noHan, XX Retinol kunye ne-riboflavin supplementation kunciphisa ukuxhaphaka kwe-anemia kwabasetyhini baseTshayina abakhulelweyo abathatha i-iron kunye ne-folic Izongezelelo zeasidi. J Amanqatha 2008; 138: 1946-1950. Jonga i-abstract.
  63. Liu, G., Lu, C., Yao, S., Zhao, F., Li, Y., Meng, X., Gao, J., Cai, J., Zhang, L., kunye no-Chen, Z. Inkqubo yeRadioosensitization ye riboflavin in vitro. Inzululwazi yeTshayina C. Ubomi beSayensi 2002; 45: 344-352. Jonga i-abstract.
  64. I-Figueiredo, JC, Levine, AJ, Grau, MV, Midttun, O., Ueland, PM, Ahnen, DJ, Barry, EL, Tsang, S., Munroe, D., Ali, I., Haile, RW, Sandler, I-RS, kunye neBaron, i-JA iVithamini B2, i-B6, kunye ne-B12 kunye nomngcipheko we-adenomas entsha ye-colorectal kuvavanyo olunokusetyenziswa kwe-aspirin kunye ne-folic acid yokuxhasa Umhlaza we-Epidemiol Biomarkers Prev 2008; 17: 2136-2145. Jonga i-abstract.
  65. McNulty, H. kunye noScott, J. M.Ukungenisa kunye nenqanaba le-folate kunye ne-B-vithamini ezinxulumene noko: ukuqaphela kunye nemiceli mngeni ekufezekiseni inqanaba elifanelekileyo. Br J Amayeza ngo-2008; 99 iSuppl 3: S48-S54. Jonga i-abstract.
  66. U-Premkumar, V. G., Yuvaraj, S., Shanthi, P., kunye no-Sachdanandam, P. Co-enzyme Q10, riboflavin kunye ne-niacin supplementation kutshintsho lwe-enzyme yokulungisa i-DNA kunye ne-DNA methylation kwizigulana ezinomhlaza wamabele ezifumana unyango lwe-tamoxifen. Br. J Nutriti 2008; 100: 1179-1182. Jonga i-abstract.
  67. Sporl, E., Raiskup-Wolf, F., kunye noPillunat, L. E. [Imigaqo ye-Biophysical ye-collagen enqamlezayo]. I-Klin Monbl kunye neAugenheilkd. Ngo-2008; 225: 131-137. Jonga i-abstract.
  68. I-Lynch, S. Impembelelo yosulelo / ukudumba, i-thalassemia kunye nenqanaba lesondlo kukufakwa kwentsimbi. I-Int J Vitam yeNutr Res 2007; 77: 217-223. Jonga i-abstract.
  69. UFischer Walker, CL, Baqui, AH, Ahmed, S., Zaman, K., El, Arifeen S., Begum, N., Yunus, M., Mnyama, RE, kunye noCaulfield, i-LE yedosi ephantsi yongezwe ngentsimbi. kunye / okanye i-zinc ayikuchaphazeli ukukhula phakathi kweentsana zaseBangladeshi. I-Eur. J yeKlinikhi yeNutr 2009; 63: 87-92. Jonga i-abstract.
  70. UKoller, T. kunye noSeiler, T. [Unyango olunqamlezayo lwe-cornea usebenzisa i-riboflavin / UVA]. I-Klin Monbl kunye neAugenheilkd. Ngo-2007; 224: 700-706. Jonga i-abstract.
  71. Ukusilela kweRiboflavin, i-galactose metabolism kunye ne-cataract. Isityhi Isityhi 1976; 34: 77-79. Jonga i-abstract.
  72. I-Premkumar, VG, Yuvaraj, S., Vijayasarathy, K., Gangadaran, SG, kunye neSachdanandam, P. Serum amanqanaba e-cytokine e-interleukin-1beta, -6, -8, tumor necrosis factor-alpha kunye ne-vascular endothelial factor factor to cancer izigulana ziphathwe nge-tamoxifen kwaye zongezwa nge-co-enzyme Q, riboflavin kunye ne-niacin. Isiseko seKlinikhi ye-Pharmacol Toxicol 2007; 100: 387-391. Jonga i-abstract.
  73. Ito, K., Hiraku, Y., kunye noKawanishi, S. I-Photosensitized DNA yomonakalo obangelwa yi-NADH: indawo ethile kunye nendlela yokusebenza. Radic yasimahla Rees 2007; 41: 461-468. Jonga i-abstract.
  74. ISrihari, G., Eilander, A., Muthayya, S., Kurpad, A. V., kunye noSeshadri, S. Inqanaba lesondlo kubantwana abafumileyo besikolo samaIndiya: yintoni kwaye siyazi kangakanani? Isilwanyana saseIndiya. Ngo-2007; 44: 204-213. Jonga i-abstract.
  75. IGariballa, S. kunye no-Ullegaddi, R. Riboflavin inqanaba lesifo esibuhlungu. I-Eur. J yeKlinikhi yeNutriti 2007; 61: 1237-1240. Jonga i-abstract.
  76. U-Singh, A., uMoses, F. M., kunye no-Deuster, P. A. Vitamin kunye nenqanaba lezimbiwa kumadoda asebenzayo: Iziphumo zokongeza amandla amakhulu. NdinguJ J Clin Nutriti 1992; 55: 1-7. Jonga i-abstract.
  77. Premkumar, V. G., Yuvaraj, S., Vijayasarathy, K., Gangadaran, S. G., kunye noSachdanandam, P. Iziphumo ze coenzyme Q10, riboflavin kunye ne-niacin kwi-serum CEA kunye ne-CA 15-3 amanqanaba kwizigulana ezinomhlaza wamabele ezifumana unyango lwe-tamoxifen. IBiol Pharm Bull. Ngo-2007; 30: 367-370. Jonga i-abstract.
  78. I-Stracciari, A., D'Alessandro, R., Baldin, E., kunye noGuarino, M. Post-transplant headache: inzuzo kwi-riboflavin. I-eurol yentsimbi. Ngo-2006; 56: 201-203. Jonga i-abstract.
  79. I-Wollensak, G. Crosslinking yonyango lwe-keratoconus eqhubekayo: ithemba elitsha. Ikhonkco Opin Ophthalmol. Ngo-2006; 17: 356-360. Jonga i-abstract.
  80. ICaporossi, A., Baiocchi, S., Mazzotta, C., Traversi, C., kunye neCaporossi, T. Unyango lweparasurgical lwekeratoconus ngohlobo lwe-riboflavin-ultraviolet uhlobo lwemitha ebangelwe kukudityaniswa kwe-corneal collagen: iziphumo zokuqala zokuphamba kwi-Italiyane. ukufunda. J Cataract Refract. Utyando. Ngo-2006; 32: 837-845. Jonga i-abstract.
  81. Bugiani, M., Lamantea, E., Invernizzi, F., Moroni, I., Bizzi, A., Zeviani, M., kunye noUziel, G. Iziphumo ze-riboflavin kubantwana abanesiphene se-II. Ubungqina beBrain Dev 2006; 28: 576-581. Jonga i-abstract.
  82. Neugebauer, J., Zanre, Y., kunye noWacker, J.Riboflavin ukuncedisa kunye ne-preeclampsia. Int Intl Gynaecol. Ngo-2006; 93: 136-137. Jonga i-abstract.
  83. UMcNulty, H., Dowey le, RC, Strain, JJ, Dunne, A., Ward, M., Molloy, AM, McAnena, LB, Hughes, JP, Hannon-Fletcher, M., noScott, uJM Riboflavin wehlisa i-homocysteine kubantu abane-homozygous ye-MTHFR 677C-> T polymorphism. Ukuhamba kwe-1-3-2006; 113: 74-80. Jonga i-abstract.
  84. USiassi, F. noGhadirian, P. Riboflavin ukusilela kunye nomhlaza wokuqaqanjelwa ngumzimba: isifundo solawulo lwamatyala eCaspian Littoral yaseIran. Ukufumana umhlaza kwangaphambili 2005; 29: 464-469. Jonga i-abstract.
  85. USandor, P. S. kunye no-Afra, J. Unpharmacologic unyango lwe-migraine. I-Curr Pain Head Head Rep 2005; 9: 202-205. Jonga i-abstract.
  86. UCiliberto, H., Ciliberto, M., Briend, A., Ashorn, P., Bier, D., noManary, M. Antioxidant supplementation yothintelo lwe-kwashiorkor kubantwana baseMalawi: ilingo elilawulwa ngokungahleliwe, elingaboniyo kabini, elilawulwa yi-placebo. BMJ 5-14-2005; 330: 1109. Jonga i-abstract.
  87. Ubunzima, uJ. J., Dowey, L., Ward, M., Pentieva, K., kunye noMcNulty, H. B-iivithamini, i-homocysteine ​​metabolism kunye neCVD. Inkqubo yeNutr Soc 2004; 63: 597-603. Jonga i-abstract.
  88. Brosnan, J.T.Homocysteine ​​kunye nesifo sentliziyo: unxibelelwano phakathi kwesondlo, ufuzo kunye nendlela yokuphila. Unako. J Appl. Physiol 2004; 29: 773-780. Jonga i-abstract.
  89. IMacdonald, H.M, McGuigan, F. E., Fraser, W., New, S., Ralston, S.H, kunye noReid, D. M. Methylenetetrahydrofolate reductase polymorphism inxibelelana nokutya kwe-riboflavin yokuchaphazela uxinano lwamaminerali. Ithambo 2004; 35: 957-964. Jonga i-abstract.
  90. UBwibo, N. O. kunye noNeumann, C. G. Isidingo sokutya kwemithombo yezilwanyana ngabantwana baseKenya. J I-2003; 133 (11 iSuppl 2): ​​3936S-3940S. Jonga i-abstract.
  91. Ipaki, YH, de Groot, L.C, kunye novan Staveren, W. A. ​​Ukutya ukutya kunye ne-anthropometry yabantu abadala baseKorea: uphononongo loncwadi. I-Asia Pac. J yeKlinikhi yeNutriti 2003; 12: 234-242. Jonga i-abstract.
  92. UDyer, A. R., Elliott, P., Stamler, J., Chan, Q., Ueshima, H., kunye noZhou, B. F. Ukutya ukutya kwabantu abatshayayo abangamadoda nabasetyhini, ababetshaya ngaphambili, kwaye bangaze batshaye: isifundo se-INTERMAP. J Hum. IiHypertens. Ngo-2003; 17: 641-654. Jonga i-abstract.
  93. Amandla, H. J. Riboflavin (vitamin B-2) kunye nempilo. NdinguJ J Clin Nutriti 2003; 77: 1352-1360. Jonga i-abstract.
  94. Hunt, I. F., Jacob, M., Ostegard, N., Masri, G., Clark, V. A., kunye noCoulson, A. H. Iziphumo zemfundo yesondlo kwisimo sesondlo sabasetyhini abakhulelweyo abanengeniso ephantsi yemvelaphi yaseMexico. NdinguJ J Clin Nutriti 1976; 29: 675-684. Jonga i-abstract.
  95. IWollensak, G., Spoerl, E., kunye neSeiler, T.Riboflavin / i-ultraviolet-a-in-collagen enqamlezileyo yokunyanga i-keratoconus. NdinguJ Ophthalmol. Ngo-2003; 135: 620-627. Jonga i-abstract.
  96. I-Navarro, M. kunye neWood, R. J.Ukutshintsha kwePlasma kwii-micronutrients kulandela ukongezwa kweemultivitamin kunye nezimbiwa kubantu abadala abasempilweni. NdinguColl Nutrr 2003; 22: 124-132. Jonga i-abstract.
  97. Moat, S. J., Ashfield-Watt, P. A., Amandla, H.J, Newcombe, R. G., kunye noMcDowell, I. F. Iziphumo zesimo se-riboflavin kwisiphumo se-homocysteine-sehla sefolate ngokunxulumene ne-genotype ye-MTHFR (C677T). Iiklinikhi Chem 2003; 49: 295-302. Jonga i-abstract.
  98. UWollensak, G., Sporl, E., noSeiler, T. [Unyango lwekeratoconus ngokudibanisa umnqamlezo]. Ophthalmologe 2003; 100: 44-49. Jonga i-abstract.
  99. Apeland, T., Mansoor, M. A., Pentieva, K., McNulty, H., Seljeflot, I., kunye noStrandjord, R. E. Iziphumo zeevithamini ze-B kwi-hyperhomocysteinemia kwizigulana ezisebenzisa iziyobisi ze-antiepileptic. Isifo sokuwa ngo-2002; 51: 237-247. Jonga i-abstract.
  100. Hustad, S., McKinley, MC, McNulty, H., Schneede, J., Strain, JJ, Scott, JM, no-Ueland, PM Riboflavin, flavin mononucleotide, kunye ne-flavin adenine dinucleotide kwi-plasma yabantu kunye ne-erythrocytes kwisiseko nasemva -dose riboflavin supplementation. Iiklinikhi Chem 2002; 48: 1571-1577. Jonga i-abstract.
  101. UMcNulty, H., McKinley, M. C., Wilson, B., McPartlin, J., Strain, J. J., Weir, D. G., noScott, J. M. Ukusebenza okungasebenzi kakuhle kwe-thermolabile methylenetetrahydrofolate reductase kuxhomekeke kwisimo se-riboflavin: iimpembelelo zeemfuno ze-riboflavin. NdinguJ J Clin Nutrit 2002; 76: 436-441. Jonga i-abstract.
  102. Yoon, HR, Hahn, SH, Ahn, YM, Jang, SH, Shin, YJ, Lee, EH, Ryu, KH, Eun, BL, Rinaldo, P., kunye noYamaguchi, S. Ityala lonyango kumatyala amathathu okuqala aseAsia. ye-ethylmalonic encephalopathy: impendulo kwi-riboflavin. J Ilifa leMetab Dis 2001; 24: 870-873. Jonga i-abstract.
  103. UDing, Z., Gao, F., kunye noLin, P. [Iziphumo zexesha elide zokunyanga abaguli abanezilonda zangaphambi komqala]. UZhonghua Zhong. Liu Za Zhi 1999; 21: 275-277. Jonga i-abstract.
  104. ULin, P., Chen, Z., Hou, J., Liu, T., kunye noWang, J. [Chemoprevention of cancer esophageal]. UZhongguo Yi Xue Ke Xue Yuan Xue Bao 1998; 20: 413-418. Jonga i-abstract.
  105. ISanchez-Castillo, CP, Lara, J., Romero-Keith, J., Castorena, G., Villa, AR, Lopez, N., Pedraza, J., Medina, O., uRodriguez, C., uChavez-Peon. , UMedina F., noJames, iWP Isondlo kunye nekati yentsimbi kubantu baseMexico abanengeniso ephantsi: amava kwinkampu yamehlo. IArch Latinoam Inutr 2001; 51: 113-121. Jonga i-abstract.
  106. Intloko, K. A. Unyango lwendalo lokuphazamiseka kwamehlo, icandelo lesibini: cataract kunye ne-glaucoma. Enye indlela. 2001; 6: 141-166. Jonga i-abstract.
  107. UMassiou, H. [Unyango lweprophylactic ye-migraine]. UMfu Neurol. (Paris) 2000; 156 Suppl 4: 4S79-4S86. Jonga i-abstract.
  108. USilberstein, S. D., Goadsby, P. J., kunye noLipton, R. B. Ulawulo lwe-migraine: indlela yealgorithmic. Neurology 2000; 55 (9 iSuppl 2): ​​S46-S52. Jonga i-abstract.
  109. Hustad, S., Ueland, P. M., Vollset, S. E., Zhang, Y., Bjorke-Monsen, A. L., noSchneede, J. Riboflavin njengommiselo weplasma iyonke i-homocysteine: ukuguqulwa kwesiphumo yi-methylenetetrahydrofolate reductase C677T polymorphism. Iiklinikhi Chem 2000; 46 (8 Pt 1): 1065-1071. Jonga i-abstract.
  110. UTaylor, P. R., Li, B., uDawsey, S. M., Li, J. Y., Yang, C. S., Guo, W., kunye noBlot, uW. J. Uthintelo lomhlaza wesophageal: izilingo zongenelelo kwisondlo eLinxian, China. Iqela leLinuxian lokuNgena kwiLingo lokuThintela amaQela.Umhlaza Res 4-1-1994; 54 (7 Suppl): 2029s-2031s. Jonga i-abstract.
  111. Blot, W. J., Li, J. Y., Taylor, P. R., Guo, W., Dawsey, S. M., noLi, B. Uvavanyo lweLinxian: amaqondo okusweleka liqela elingenelela ngevithamini. NdinguJ J Nutriti 1995; 62 (6 Suppl): 1424S-1426S. Jonga i-abstract.
  112. Qu, CX, Kamangar, F., Fan, JH, Yu, B., Ilanga, XD, Taylor, PR, Chen, BE, Abnet, CC, Qiao, YL, Mark, SD, kunye noDawsey, SM Chemoprevention yesibindi sokuqala Umhlaza: ityala elingahleliwe, elingaboniyo kabini eLinxian, China. J Natl. Umhlaza Inst. 8-15-2007; 99: 1240-1247. Jonga i-abstract.
  113. IBates, CJ, Evans, PH, Allison, G., Sonko, BJ, Hoare, S., Goodrich, S., kunye no-Aspray, T. indices ze-biochemical kunye neemvavanyo zomsebenzi we-neuromuscular kubantwana besikolo baseGambia abanikwe i-riboflavin, okanye i-multivitamin kunye ne-iron , isongezelelo. UBr. J. Nutrr. Ngo-1994; 72: 601-610. Jonga i-abstract.
  114. I-Charoenlarp, ​​P., Pholpothi, T., Chatpunyaporn, P., kunye ne-Schelp, F. P. Iziphumo ze riboflavin kutshintsho lwehematologic kulongezo lwentsimbi lwabantwana besikolo. Umzantsi mpuma weAsia J. Troped. Impilo yoLuntu ka-1980; 11: 97-103. Jonga i-abstract.
  115. Amandla, H.J, Bates, C. J., Prentice, A.M, Lamb, W.H, Jepson, M., kunye noBowman, H.Ukusebenza ngokuhambelana kwentsimbi kunye nentsimbi kunye ne-riboflavin ukulungisa i-anemia ye-microcytic emadodeni nakubantwana abasemaphandleni eGambia. Umkhuhlane weKlinikhi. Ngo-1983; 37: 413-425. Jonga i-abstract.
  116. Bates, C. J., Amandla, H.J, iMvana, W.H, Gelman, W., kunye neWebb, E.Iziphumo zevithamini ezongezelelweyo kunye nentsimbi kwiimpawu ze-malaria kubantwana baseGambia basemaphandleni. Trans.R.Soc.Isixhobo.IMed.Hyg. Ngowe-1987; 81: 286-291. Jonga i-abstract.
  117. Kabat, G. C., Miller, A. B., Jain, M., kunye noRohan, T. E. Ukutya ukutya kweevithamini ze-B ezikhethiweyo ngokunxulumene nomngcipheko wee-cancer ezinkulu kubafazi. Br. J. Umhlaza 9-2-2008; 99: 816-821. Jonga i-abstract.
  118. UMcNulty, H., Pentieva, K., Hoey, L., kunye neWard, M. Homocysteine, B-iivithamini kunye neCVD. Inkqubo yeNutr Soc. Ngo-2008; 67: 232-237. Jonga i-abstract.
  119. Stott, DJ, MacIntosh, G., Lowe, GD, Rumley, A., McMahon, AD, Langhorne, P., Tait, RC, O'Reilly, DS, Spilg, EG, MacDonald, JB, MacFarlane, PW, kunye I-Westendorp, i-RG Isilingo esilawulwa ngokungahleliwe sonyango lwe-homocysteine-ukwehlisa unyango kwizigulana ezalupheleyo ezinesifo semithambo. NdinguJ. Kliniki uNutr. 2005; 82: 1320-1326. Jonga i-abstract.
  120. Modi, S. kunye no-Lowder, D. M. Amayeza e-migraine prophylaxis. Ndingu Fam. Ugqirha 1-1-2006; 73: 72-78. Jonga i-abstract.
  121. I-Woolhouse, M. Migraine kunye nobunzima beentloko-indlela ehambelanayo kunye neyeza. Aust Fam. Ugqirha 2005; 34: 647-651. Jonga i-abstract.
  122. I-Premkumar, V. G., Yuvaraj, S., Sathish, S., Shanthi, P., kunye neSachdanandam, P. Amandla okulwa ne-angiogenic e-CoenzymeQ10, riboflavin kunye ne-niacin kwizigulana ezinomhlaza wamabele ezifumana unyango lwe-tamoxifen. IVascul. IPharmacol. Ngo-2008; 48 (4-6): 191-201. Jonga i-abstract.
  123. Tepper, S. J. Unyango olongezelelekileyo nolunye unyango lwentloko yabantwana. I-Curr Pain Head Head Rep. 2008; 12: 379-383. Jonga i-abstract.
  124. I-Kamangar, F., Qiao, YL, Yu, B., Ilanga, i-XD, i-Abnet, i-CC, iFan, i-JH, iMark, i-SD, i-Zhao, i-P., i-Dawsey, i-SM kunye ne-Taylor, i-PR yomhlaza wemiphunga yokuthintela umhlaza: ityala elingaboniyo kabini eLinxian, China. Umhlaza we-Epidemiol. Ngo-2006; 15: 1562-1564. Jonga i-abstract.
  125. I-Sun-Edelstein, C. kunye neMauskop, A. Ukutya kunye nezongezo kulawulo lwentloko ye-migraine. Iiklinikhi J buhlungu 2009; 25: 446-452. Jonga i-abstract.
  126. I-Shargel L, i-Mazel P. Iziphumo zokusilela kwe-riboflavin kwi-phenobarbital kunye ne-3-methylcholanthrene induction ye-microsomal drug-metabolizing enzymes ye-rat. Biochem Pharmacol. Ngo-1973; 22: 2365-73. Jonga i-abstract.
  127. I-Fairweather-Tait SJ, Amandla HJ, Minski MJ, et al. Ukusilela kweRiboflavin kunye nokufakwa kwesinyithi kumadoda amadala aseGambia. UAnn Nutrab Metab. Ngo-1992; 36: 34-40. Jonga i-abstract.
  128. ILeeson LJ, i-Weidenheimer JF. Uzinzo lwe-tetracycline kunye ne-riboflavin. J Amayeza eSayensi. Ngo-1969; 58: 355-7. Jonga i-abstract.
  129. UPringsheim T, uDavenport W, uMackie G, et al. Isikhokelo seCanada seNtloko yeNtloko yesikhokelo se-migraine prophylaxis. Ngaba uJ Neurol. Sci. 2012; 39: S1-59. Jonga i-abstract.
  130. IHolland S, uSilberstein SD, uFreitag F, et al. Ukuhlaziywa kwesikhokelo esisekwe kubungqina: Ii-NSAID kunye nolunye unyango olongezelelekileyo kuthintelo lwe-episodic migraine kubantu abadala: Ingxelo yeKomitana yamaGangatho emiGangatho yeAmerican Academy ye-Neurology kunye noMbutho weNtloko waseMelika. Neurology 2012; 78: 1346-53. Jonga i-abstract.
  131. UJacques PF, uTaylor A, uMoeller S, et al. Ukutya ixesha elide kwezondlo kunye notshintsho lweminyaka emi-5 kwii-opacities zenyukliya. IArch Ophthalmol 2005; 123: 517-26. Jonga i-abstract.
  132. I-Maizels M, iBlumenfeld A, iBurchette R.Udibaniso lwe-riboflavin, i-magnesium, kunye ne-feverfew ye-migraine prophylaxis: ityala elingahleliwe. Intloko ye2004; 44: 885-90. Jonga i-abstract.
  133. UBoehnke C, Reuter U, Flach U, et al. Unyango lwe-riboflavin yonyango olusebenzayo luyasebenza kwimigraine prophylaxis: isifundo esivulekileyo kwiziko lokhathalelo oluphezulu. I-Eur J Neurol 2004; 11: 475-7. Jonga i-abstract.
  134. USandor PS, uDi Clemente L, uCoppola G, et al. Ukusebenza kwecoenzyme Q10 kwi-migraine prophylaxis: Uvavanyo olulawulwa ngokungenamthetho. Neurology 2005; 64: 713-5. Jonga i-abstract.
  135. UHernandez BY, McDuffie K, uWilkens LR, et al. Ukutya kunye nezilonda zangaphambi kwesibeleko somlomo wesibeleko: ubungqina bendima ekhuselayo yefolate, riboflavin, thiamin, kunye nevithamini B12. Ulawulo lweZibangela zoMhlaza 2003; 14: 859-70. Jonga i-abstract.
  136. ISkalka HW, iPrchal JT. Ukutsalwa kwe-cataract kunye ne-riboflavin. NdinguJ J Clin Nutriti 1981; 34: 861-3 .. Jonga i-abstract.
  137. IBell IR, uEdman JS, uMorrow FD, et al. Unxibelelwano olufutshane. I-Vitamin B1, B2, kunye ne-B6 yokunyusa unyango lwe-tricyclic antidepressant kuxinzelelo lwe-geriatric ngokungasebenzi kakuhle kwengqondo. J NdinguColl Nutriti 1992; 11: 159-63 .. Jonga i-abstract.
  138. UNegri E, uFranceschi S, uBostiti C, et al. I-micronutrients ekhethiweyo kunye nomhlaza womlomo kunye ne-pharyngeal. Int J Umhlaza 2000; 86: 122-7 .. Jonga i-abstract.
  139. IVir SC, Uthando AH. Isondlo seRiboflavin sabasebenzisi bokukhulelwa komlomo. I-Int J Vitam Nutr Res 1979; 49: 286-90 .. Jonga i-abstract.
  140. U-Hamajima S, u-Ono S, u-Hirano H, u-Obara K.Ukwenziwa kwenkqubo ye-FAD synthetase kwisibindi se-rat ngolawulo lwe-phenobarbital. I-Int J Vit Nutr Res 1979; 49: 59-63 .. Jonga i-abstract.
  141. I-Ohkawa H, i-Ohishi N, i-Yagi K. I-Hydroxylation ye-7 kunye ne-8-methyl yamaqela e-riboflavin yinkqubo yokudlulisa i-electron microsomal ye-rat isibindi. J Biol Chem 1983; 258: 5629-33 .. Jonga i-abstract.
  142. UPinto J, Huang YP, uPelliccione N, uRivlin RS. I-Adriamycin inhibit synthesis syntax ye-flavin entliziyweni: ubudlelwane obunokwenzeka ne-cardiotoxicity ye-anthracyclines (abstract). Iklinikhi Res 1983; 31; 467A.
  143. I-Raiczyk GB, i-Pinto J. Inhibition ye-flavin metabolism yi-adriamycin kwimisipha yamathambo. I-Biochem Pharmacol 1988; 37: 1741-4 .. Jonga i-abstract.
  144. Ogura R, Ueta H, Hino Y, et al. Ukusilela kweRiboflavin kubangelwa lunyango lwe-adriamycin. J Nutr Sci Vitaminol 1991; 37: 473-7 .. Jonga i-abstract.
  145. U-Lewis CM, uKing JC. Iziphumo zokukhulelwa komlomo kwi-thiamin, riboflavin, kunye nenqanaba le-asidi ye-pantothenic kubafazi abancinci. NdinguJ J Clin Nutriti 1980; 33: 832-8 .. Jonga i-abstract.
  146. Roe DA, Bogusz S, Sheu J, okqhubekayo. Izinto ezichaphazela iimfuno ze-riboflavin zabasebenzisi bokucwangcisa ngomlomo kunye nabangengabo abasebenzisi. NdinguJ J Clin Nutriti 1982; 35: 495-501 .. Jonga i-abstract.
  147. UNewman LJ, uLopez R, uCole HS, et al. Ukusilela kweRiboflavin kwabasetyhini abathatha ii-arhente zokucwangcisa ngomlomo. NdinguJ J Clin Nutrt 1978; 31: 247-9 .. Jonga i-abstract.
  148. Briggs M. Izicwangcisi zomlomo kunye nesondlo sevithamini (ileta). ILancet 1974; 1: 1234-5. Jonga i-abstract.
  149. U-Ahmed F, uBamji MS, u-Iyengar L. Iziphumo zearhente yokuthintela ukukhulelwa yomlomo kwimo yesondlo sevithamini. NdinguJ J Clin Nutriti 1975; 28: 606-15 .. Jonga i-abstract.
  150. Dutta P, Pinto J, Rivlin R.Iziphumo ze-Antimalarial zokunqongophala kwe-riboflavin. ILancet 1985; 2: 1040-3. Jonga i-abstract.
  151. I-Raiczyk GB, iDutta P, iPinto J. Chlorpromazine kunye nequinacrine inhibit flavin adenine dinucleotide biosynthesis kwimisipha yamathambo. Inzululwazi yezamayeza 1985; 28: 322.
  152. IPelliccione N, uPinto J, uHuang YP, uRivlin RS. Ukukhula ngokukhawuleza kokunqongophala kwe-riboflavin ngonyango lwe-chlorpromazine. I-Biochem Pharmacol 1983; 32: 2949-53 .. Jonga i-abstract.
  153. UPinto J, Huang YP, uPelliccione N, uRivlin RS. Ubuntununtunu be-Cardiac kwiziphumo zokuthintela i-chlorpromazine, imipramine, kunye ne-amitriptyline xa kusenziwa iincasa. I-Biochem Pharmacol 1982; 31: 3495-9 .. Jonga i-abstract.
  154. I-Pinto J, i-Huang YP, iRivlin RS. Ukuthintela i-riboflavin metabolism kwimisipha ye-rat yi-chlorpromazine, imipramine kunye ne-amitriptyline. J Utyalomali 1981; 67: 1500-6. Jonga i-abstract.
  155. UJusko WJ, uLevy G, uYaffe SJ, uGorodischer R. Iziphumo zeprobenecid ekususeni i-riboflavin kwindoda. J Pharm Sci 1970; 59: 473-7. Jonga i-abstract.
  156. I-Jusko WJ, i-Levy G. Iziphumo ze-probenecid ekufunxweni kwe-riboflavin kunye nokukhupha emntwini. J Pharm Sci 1967; 56: 1145-9. Jonga i-abstract.
  157. Yanagawa N, Shih RN, Jo OD, utshilo u-HM. Uthutho lweRiboflavin ngotywala lwe-renal proximal tubules. NdinguJ J Physiol Cell Physiol 2000; 279: C1782-6 .. Jonga i-abstract.
  158. UDalton SD, uRahimi AR. Indima evelayo ye-riboflavin kunyango lwe-nucleoside analogue-indened type B lactic acidosis. Uncedo lwe-AIDS kwi-STDS ngo-2001; 15: 611-4 .. Jonga okungafakwanga.
  159. Roe DA, Kalkwarf H, Stevens J. Iziphumo zezongezo zefayibha ekufumaneni okubonakalayo kwethamo le-pharmacological ye-riboflavin. J Am Diet Assoc 1988; 88: 211-3 .. Jonga i-abstract.
  160. I-Pinto J, i-Raiczyk GB, i-Huang YP, iRivlin RS. Iindlela ezintsha zokuthintela iziphumo ebezingalindelekanga zekhemotherapy ngesondlo. Umhlaza 1986; 58: 1911-4 .. Jonga i-abstract.
  161. UMcCormick DB. Riboflavin. Ku: Shils ME, Olson JA, Shike M, Ross AC, ii-eds. Isondlo sangoku kwezempilo nakwizifo. Umhla we-9. IBaltimore, MD: Williams kunye noWilkins, 1999. iphe. 391-9.
  162. I-Fishman SM, i-Christian P, i-West KP. Indima yeevithamini kuthintelo kunye nolawulo lwe-anemia. Impilo yoLuntu kwiZondlo 2000; 3: 125-50 .. Jonga i-abstract.
  163. ITyrer LB. Isondlo kunye nepilisi. J Reprod Med 1984; 29: 547-50 .. Jonga i-abstract.
  164. Mooij PN, Thomas CM, Doburg WH, Eskes TK. Ukuxhaswa kweMultivitamin kubasebenzisi bokukhulelwa komlomo. Ukuthintela ukukhulelwa 1991; 44: 277-88. Jonga i-abstract.
  165. USazawal S, uMnyama RE, uMenon VP, et al. Ukongezwa kwe-Zinc kwiintsana ezizalwe zincinci kubudala bokukhulelwa kunciphisa ukubhubha: ulingo olulindelekileyo, olungenamkhethe, olulawulwayo. Iipedatifikethi 2001; 108: 1280-6. Jonga i-abstract.
  166. Cumming RG, Mitchell P, Smith W.Ukutya kunye ne-cataract: iBlue Mountains Eye Study. Ophthalmology 2000; 10: 450-6. Jonga i-abstract.
  167. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukufakwa kwereferensi yokutya kwi-Thiamin, i-Riboflavin, i-Niacin, i-Vitamin B6, i-Folate, i-Vitamin B12, i-Pantothenic Acid, i-Biotin kunye ne-Choline. IWashington, DC: ICandelo leSizwe lezeMfundo, 2000. Iyafumaneka kwi: http://books.nap.edu/books/0309065542/html/.
  168. Kulkarni PM, Schuman PC, Merlino NS, Kinzie JL. I-Lactic acidosis kunye ne-hepatic steatosis kwizigulana ezinesifo se-HIV eziphathwe nge-nucleoside analogue. Iprojekthi yeNatl AIDS yoNyango. Iveki yeZigulo zeSifo seSibindi, iSan Diego, CA. Ngo-2000; ngoMeyi 21-4: Rep11.
  169. Ikhowudi yeKhompyuter yeMigaqo yeFederal. Itayitile 21. Icandelo le-182 -Iziyobisi zivunywa ngokubanzi njengezikhuselekileyo. Ifumaneka kwi: https://www.accessdata.fda.gov/script/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  170. ISparduto RD, i-Hu TS, iMilton RC, et al. Izifundo zelinacian cataract. Izilingo ezimbini zongenelelo ngoncedo. IArch Ophthalmol 1993; 111: 1246-53. Jonga i-abstract.
  171. UWang GQ, uDawsey SM, uLi JY, et al. Iziphumo zokuncedisa iivithamini / izimbiwa kukuxhaphaka kwe-histological dysplasia kunye nomhlaza wokuqala wesisu kunye nesisu: iziphumo ezivela kuvavanyo oluPhezulu lwaBantu eLinxian, China. Umhlaza we-Epidemiol Biomarkers Prev 1994; 3: 161-6. Jonga i-abstract.
  172. INimmo WS. Iziyobisi, izifo, kunye notshintsho lwento esiswini. Kwiiklinikhi zeFarmacokinet 1967; 1: 189-203. Jonga i-abstract.
  173. ISanpitak N, Chayutimonkul L. Izinto zokucwangcisa zomlomo kunye nesondlo se-riboflavin. ILancet 1974; 1: 836-7. Jonga i-abstract.
  174. I-Hill MJ. Iintyatyambo zamathumbu kunye ne-vitamin endo native synthesis. I-Eur J Cancer ngaphambili 1997; 6: S43-5. Jonga i-abstract.
  175. IiYates AA, iSchlicker SA, iSuitor CW. Ukungeniswa kwereferensi yezidlo J Nditya i-Assoc 1998; 98: 699-706. Jonga i-abstract.
  176. UKastrup EK. Iinyani ngeziyobisi kunye nokuThelekisa. Ngo-1998 kuhleliwe. I-St. Louis, MO: Iinyani kunye nokuthelekisa, 1998.
  177. UMark SD, uWang W, uFraumeni JF Jr, et al. Ngaba izongezo zesondlo ziyawunciphisa umngcipheko wokubetha okanye uxinzelelo lwegazi? Epidemiology 1998; 9: 9-15. Jonga i-abstract.
  178. IBlot WJ, uLi JY, uTaylor PR. Izilingo zongenelelo kwizondlo eLinxian, China: ukongezwa kunye nokudityaniswa kweevithamini / izimbiwa ezithile, izehlo zomhlaza, kunye nokufa okuthe ngqo kubantu ngokubanzi. J Natl Cancer Inst 1993; 85: 1483-92. Jonga i-abstract.
  179. UFouty B, uFrrman F, u-Reves R. Riboflavin ukunyanga i-lactic acidosis ye-nucleoside analogue. ILancet 1998; 352: 291-2. Jonga i-abstract.
  180. I-Schoenen J, uJacquy J, uLenaerts M. Ukuphumelela kwethamo eliphezulu le-riboflavin kwimigraine prophylaxis. Ulingo olulawulwa ngokungenamthetho. NeurologyI-1998; 50: 466-70. Jonga i-abstract.
  181. I-Schoenen J, i-Lenaerts M, i-Bastings E. I-dose ephezulu ye-riboflavin njengonyango lwe-migraine: iziphumo zesifundo somqhubi ovulekileyo. ICephalalgia 1994; 14: 328-9. Jonga i-abstract.
  182. I-Sandor PS, i-Afra J, i-Ambrosini A, i-Schoenen J. Prophylactic yonyango lwe-migraine kunye ne-beta-blockers kunye ne-riboflavin: umahluko kwiziphumo zokuxhomekeka kokuqina kokuvavanywa kwamandla e-cortical. Intloko ye2000; 40: 30-5. Jonga i-abstract.
  183. I-Kunsman GW, uLevine B, uSmith ML. Ukuphazamiseka kweVitamin B2 kunye neziyobisi ezisebenzisa kakubi iziyobisi. J Forensic Sci 1998; 43: 1225-7. Jonga i-abstract.
  184. IGupta SK, iGupta RC, uSeth AK, uGupta A.Ukuguqulwa kwefluorosis ebantwaneni. I-Acta Paediatr Jpn 1996; 38: 513-9. Jonga i-abstract.
  185. UHardman JG, uLimbird LL, uMolinoff PB, ii-eds. UGoodman noGillman's Isiseko seFarmacological of Therapeutics, umhla we-9. ENew York, NY: McGraw-Hill, 1996.
  186. I-DS encinci. Iziphumo zeziyobisi kuvavanyo lweelebhu zeklinikhi 4th ed. IWashington: I-AACC Press, ngo-1995.
  187. UMcEvoy GK, ed. Ulwazi lwe-AHFS yeziyobisi. I-Bethesda, MD: Umbutho waseMelika we-Health-System Pharmacists, 1998.
  188. Foster S, uTyler VE. I-Herbal ethembekileyo yeTyler: Isikhokelo esiSebenzisayo sokuSebenzisa iiHerbs kunye neZonyango ezinxulumene noko. I-3rd ed., IBinghamton, NY: I-Haworth Herbal Press, ngo-1993.
  189. INewall CA, uAnderson LA, uPhilpson JD. Unyango ngamayeza esintu: Isikhokelo saBasebenzi bezeMpilo. ILondon, e-UK: Icandelo leendaba lonyango, ngo-1996.
  190. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
  191. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
  192. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Ukuhlaziywa okokugqibela-08/19/2020

Kucetyiswa Wena

Izicwangciso zoNyango lweMedare: Into ekufuneka uyazi ngeMedigap
Zempilo

Izicwangciso zoNyango lweMedare: Into ekufuneka uyazi ngeMedigap

Izicwangci o zokuncedi a kwi-Medicare zizicwangci o ze-in huren i zabucala eziyilelwe ukuzali a ezinye zezikhewu kwi-Medicare. Nge i izathu, abantu bakwabiza le nkqubo njengeMedigap. I-in huren i yoku...
Yintoni ebangela ukuvuswa rhoqo kwaye ukuba ufuna ukwenza nantoni na malunga nayo
Zempilo

Yintoni ebangela ukuvuswa rhoqo kwaye ukuba ufuna ukwenza nantoni na malunga nayo

Ivumba lecologne yeqabane lakho; ukubamba iinwele zabo kulu u lwakho. Iqabane elipheka i idlo; iqabane elikhokelayo kwimeko ene iphithiphithi.Imidla ye ondo kunye nokujika kuyahluka kuye ngomntu. Yint...